Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Early relapse on adjuvant gemcitabine associated with an exceptional response to 2nd line capecitabine chemotherapy in a patient with pancreatic adenosquamous carcinoma with strong intra-tumoural expression of cytidine deaminase: a case report

Fig. 2

Radiological progression of liver metastases, by unenhanced CT. a baseline liver free of metastatic disease; b new liver lesions in segments 7 and 8 (solid arrows) 1.8 months into gemcitabine therapy; c high attenuation calcification of pre-existing liver lesions (solid arrows) and further low attenuation cystic components (dashed arrow) 13.8 months into capecitabine therapy; d stable liver disease 32.3 months into capecitabine therapy; e increase in size of segment 8 liver lesion (solid arrow) 34.6 months into capecitabine therapy; f stable liver disease 13.3 months into modified FOLFIRINOX therapy

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us